Literature DB >> 28243940

Modulation of the host immune response by respiratory syncytial virus proteins.

Megan E Schmidt1, Steven M Varga2,3,4.   

Abstract

Respiratory syncytial virus (RSV) causes severe respiratory disease in both the very young and the elderly. Nearly all individuals become infected in early childhood, and reinfections with the virus are common throughout life. Despite its clinical impact, there remains no licensed RSV vaccine. RSV infection in the respiratory tract induces an inflammatory response by the host to facilitate efficient clearance of the virus. However, the host immune response also contributes to the respiratory disease observed following an RSV infection. RSV has evolved several mechanisms to evade the host immune response and promote virus replication through interactions between RSV proteins and immune components. In contrast, some RSV proteins also play critical roles in activating, rather than suppressing, host immunity. In this review, we discuss the interactions between individual RSV proteins and host factors that modulate the immune response and the implications of these interactions for the course of an RSV infection.

Entities:  

Keywords:  RSV; T cell; lung; vaccine; virus

Mesh:

Substances:

Year:  2017        PMID: 28243940     DOI: 10.1007/s12275-017-7045-8

Source DB:  PubMed          Journal:  J Microbiol        ISSN: 1225-8873            Impact factor:   2.902


  114 in total

1.  The small hydrophobic protein of the human respiratory syncytial virus forms pentameric ion channels.

Authors:  Siok-Wan Gan; Edward Tan; Xin Lin; Dejie Yu; Juejin Wang; Gregory Ming-Yeong Tan; Ardcharaporn Vararattanavech; Chiew Ying Yeo; Cin Huang Soon; Tuck Wah Soong; Konstantin Pervushin; Jaume Torres
Journal:  J Biol Chem       Date:  2012-05-23       Impact factor: 5.157

2.  Enhanced disease and pulmonary eosinophilia associated with formalin-inactivated respiratory syncytial virus vaccination are linked to G glycoprotein CX3C-CX3CR1 interaction and expression of substance P.

Authors:  Lia M Haynes; Les P Jones; Albert Barskey; Larry J Anderson; Ralph A Tripp
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

3.  Respiratory syncytial virus G and/or SH protein alters Th1 cytokines, natural killer cells, and neutrophils responding to pulmonary infection in BALB/c mice.

Authors:  R A Tripp; D Moore; L Jones; W Sullender; J Winter; L J Anderson
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

4.  Respiratory syncytial virus infections in previously healthy working adults.

Authors:  C B Hall; C E Long; K C Schnabel
Journal:  Clin Infect Dis       Date:  2001-08-21       Impact factor: 9.079

5.  NF-κB mediates IL-1β- and IL-17A-induced MUC5B expression in airway epithelial cells.

Authors:  Tomoyuki Fujisawa; Mary Mann-Jong Chang; Sharlene Velichko; Philip Thai; Li-Yin Hung; Fei Huang; Newton Phuong; Yin Chen; Reen Wu
Journal:  Am J Respir Cell Mol Biol       Date:  2010-10-08       Impact factor: 6.914

6.  Respiratory syncytial virus nonstructural proteins decrease levels of multiple members of the cellular interferon pathways.

Authors:  Samer Swedan; Alla Musiyenko; Sailen Barik
Journal:  J Virol       Date:  2009-07-22       Impact factor: 5.103

7.  Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice.

Authors:  B S Graham; L A Bunton; P F Wright; D T Karzon
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

8.  Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages [corrected].

Authors:  Kirsten M Spann; Kim-C Tran; Bo Chi; Ronald L Rabin; Peter L Collins
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

9.  Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis.

Authors:  Teluguakula Narasaraju; Edwin Yang; Ramar Perumal Samy; Huey Hian Ng; Wee Peng Poh; Audrey-Ann Liew; Meng Chee Phoon; Nico van Rooijen; Vincent T Chow
Journal:  Am J Pathol       Date:  2011-05-07       Impact factor: 4.307

10.  TLR-4 and CD14 polymorphisms in respiratory syncytial virus associated disease.

Authors:  Beena Puthothu; Johannes Forster; Andrea Heinzmann; Marcus Krueger
Journal:  Dis Markers       Date:  2006       Impact factor: 3.434

View more
  10 in total

1.  Infant Viral Respiratory Infection Nasal Immune-Response Patterns and Their Association with Subsequent Childhood Recurrent Wheeze.

Authors:  Kedir N Turi; Jyoti Shankar; Larry J Anderson; Devi Rajan; Kelsey Gaston; Tebeb Gebretsadik; Suman R Das; Cosby Stone; Emma K Larkin; Christian Rosas-Salazar; Steven M Brunwasser; Martin L Moore; R Stokes Peebles; Tina V Hartert
Journal:  Am J Respir Crit Care Med       Date:  2018-10-15       Impact factor: 21.405

2.  Ephedrannin B exerts anti-viral and anti-inflammatory properties in BEAS-2B cells infected with respiratory syncytial virus.

Authors:  Shu Hou; Xiaoyan Xu; Yating Wang; Yan Yang
Journal:  J Biosci       Date:  2020       Impact factor: 1.826

3.  Juvenile, but Not Adult, Mice Display Increased Myeloid Recruitment and Extracellular Matrix Remodeling during Respiratory Syncytial Virus Infection.

Authors:  Gerald G Kellar; Stephen R Reeves; Kaitlyn A Barrow; Jason S Debley; Thomas N Wight; Steven F Ziegler
Journal:  J Immunol       Date:  2020-10-23       Impact factor: 5.422

4.  Vaccine containing G protein fragment and recombinant baculovirus expressing M2 protein induces protective immunity to respiratory syncytial virus.

Authors:  Yeong-Min Jo; Jungwoo Kim; Jun Chang
Journal:  Clin Exp Vaccine Res       Date:  2019-01-31

Review 5.  Biology of Infection and Disease Pathogenesis to Guide RSV Vaccine Development.

Authors:  Seyhan Boyoglu-Barnum; Tatiana Chirkova; Larry J Anderson
Journal:  Front Immunol       Date:  2019-07-25       Impact factor: 7.561

Review 6.  Revisiting respiratory syncytial virus's interaction with host immunity, towards novel therapeutics.

Authors:  C Efstathiou; S H Abidi; J Harker; N J Stevenson
Journal:  Cell Mol Life Sci       Date:  2020-06-16       Impact factor: 9.261

Review 7.  A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir.

Authors:  Chengyuan Liang; Lei Tian; Yuzhi Liu; Nan Hui; Guaiping Qiao; Han Li; Zhenfeng Shi; Yonghong Tang; Dezhu Zhang; Xiaolin Xie; Xu Zhao
Journal:  Eur J Med Chem       Date:  2020-06-06       Impact factor: 6.514

8.  Mutation in the CX3C Motif of G Protein Disrupts Its Interaction with Heparan Sulfate: A Calorimetric, Spectroscopic, and Molecular Docking Study.

Authors:  Abu Hamza; Abdus Samad; Zahoor Ahmad Parray; Sajda Ara; Anwar Ahmed; Fahad N Almajhdi; Tajamul Hussain; Asimul Islam; Shama Parveen
Journal:  Int J Mol Sci       Date:  2022-02-09       Impact factor: 5.923

9.  The effect of carvacrol on respiratory syncytial virus infection in mice model: caution in the use of herbal medicines.

Authors:  Marzieh Faraji-Zonouz; Farshad Khodakhah; Forough Tavakoli; Alireza Tahamtan; Masoumeh Tavakoli-Yaraki; Farhad Rezaie; Talat Mokhatri-Azad; Vahid Salimi
Journal:  Iran J Microbiol       Date:  2021-10

Review 10.  Hydrogen sulfide in physiology and pathogenesis of bacteria and viruses.

Authors:  Virender Kumar Pal; Parijat Bandyopadhyay; Amit Singh
Journal:  IUBMB Life       Date:  2018-03-30       Impact factor: 3.885

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.